➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
Johnson and Johnson
McKesson
McKinsey
Moodys

Last Updated: August 10, 2020

DrugPatentWatch Database Preview

G And W Labs Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for G AND W LABS, and what generic and branded alternatives to G AND W LABS drugs are available?

G AND W LABS has twelve approved drugs.



Summary for G And W Labs
US Patents:0
Tradenames:12
Ingredients:12
NDAs:12

Drugs and US Patents for G And W Labs

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
G And W Labs Inc NYSTATIN nystatin SUSPENSION;ORAL 062349-001 Jul 14, 1982 DISCN No No   Start Trial   Start Trial
G And W Labs Inc CAPTOPRIL captopril TABLET;ORAL 074590-003 Aug 30, 1996 DISCN No No   Start Trial   Start Trial
G And W Labs Inc METAPROTERENOL SULFATE metaproterenol sulfate SYRUP;ORAL 073034-001 Aug 30, 1991 DISCN No No   Start Trial   Start Trial
G And W Labs Inc CAPTOPRIL captopril TABLET;ORAL 074590-004 Aug 30, 1996 DISCN No No   Start Trial   Start Trial
G And W Labs Inc MESALAMINE mesalamine ENEMA;RECTAL 076841-001 Sep 30, 2004 DISCN No No   Start Trial   Start Trial
G And W Labs Inc CIMETIDINE HYDROCHLORIDE cimetidine hydrochloride SOLUTION;ORAL 074176-001 Jun 1, 1994 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Harvard Business School
McKesson
Moodys
Dow
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.